Mark Goldstone

Mark Goldstone

Chief Executive Officer at GUARDION HEALTH SCIENCES, INC.
62 year
Commercial Services
Technology Services
Health Technology

Profile

Mark Goldstone is the founder of Ansella Therapeutics, Inc. He currently holds multiple positions, including President, Chief Executive Officer & Director at Guardion Health Sciences, Inc., Director at Global Genomics Group, Director at Galien Foundation, Director at BeCare Link LLC, and Member at Royal Pharmaceutical Society of Great Britain.
In the past, he served as Chief Executive Officer-Healthcare Business at Interbrand Corp., Co-Chief Executive Officer at Medikly, Inc., Co-Chairman-New York Corporate Development at American Diabetes Association, Director at Neuroview Technology, Inc., Director at BayBridgeDigital LLC, President-Healthcare Business at DDB Worldwide Communications Group LLC, Principal at Publicis Healthcare Communications Group, Inc., and Chief Operating Officer at HAVAS & JOY, S.C.

Mark Goldstone active positions

CompaniesPositionStart
GUARDION HEALTH SCIENCES, INC. Chief Executive Officer 17/10/2024
Director/Board Member 31/12/2010
Director/Board Member -
Corporate Officer/Principal -
Director/Board Member -

Former positions of Mark Goldstone

CompaniesPositionEnd
Corporate Officer/Principal 31/12/2012
Chief Operating Officer -
Founder -
Director/Board Member -
░░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
See the detail of Mark Goldstone's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

82

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Technology Services

Health Technology

Commercial Services

Health Technology

Technology Services

Technology Services

Technology Services

Health Technology

Commercial Services

  1. Stock Market
  2. Insiders
  3. Mark Goldstone
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!